SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OLD JAKE JUSTUS who wrote (365)6/10/1998 4:32:00 PM
From: Mark C.  Read Replies (2) of 4891
 
I have been in ADVR for only a few months. While doing some research into it I ran across the following, I did not see it posted previously if it has been sorry for the repost.

RETICULOSE

Significant CD4 Increases Documented

Reticulose is an injectable product derived from Colostrum with RNA added that comes in 2 ml ampules. The only
contra-indications are tuberculosis and severe bovine serum allergy. Reticulose is effective for the following conditions:
AIDS, Hepatitis A, B and C, Herpes, Influenza A, Mononucleosis, Encephalitis, Dengue fever and upper respiratory
infections. The standard dose is one injection daily of a 2 ml ampule for 7 days. Then none for the next seven days. The third
week - one injection daily for 7 days and one then week off. The Fifth week is the last treatment in the series. Blood work is
done in the 8th week.

There are several Physicians that have used Reticulose in their practice with excellent results. They are: Ralph Thompson,
MD of Alexandria, VA; Margaret Reynolds, MD of Petersborough, NH; Morris Kuckku, MD of Miami, FL; Oden Schaeffer,
MD of Miami, FL; Frank Seydel, MD of Boulder, CO; Stanford Cooke, MD of Miami, FL; Lawrence Medoff, MD of Miami,
FL; Robert Anderson MD of Alexandria, VA; S.J. Plucinski, MD of Miami Shores, FL; Reticulose's Effects on CD4 Counts
9 out of 10 show significant increases In 1992, Angelo Chinnici, MD of Ashbury Park, NJ wrote of the results of a 6 week
evaluation of Reticulose in 10 AIDS patients. The most dramatic case was one PWA whose CD4 count increased from 27 to
193 in 6 weeks. The average CD4 count of all 10 patients was 246 at the beginning of the study. After 6 weeks, the average
CD4 count was 407. Nine out of ten also had increases in the CD4/CD8 ratios. No evidence of toxicity was observed in any
of the patients. All ten patients who were P24 antigen positive at the beginning of the study were P24 antigen negative after 8
weeks. No PCR tests were done in this study. PCR is the most accurate test for HIV viral load known today. The P24 antigen
test is not nearly as accurate. One test result showed a person was cured of Hepatitis C after one series of shots.

Reticulose was once legally available in the United States, but the FDA has since determined that it is an unapproved new
drug. However, under the FDA's new compassionate use policy, it may be legally imported into the United States with a
Physicians prescription. For more information, write, Commonwealth Pharmaceuticals, PO Box 1792, Grand Cayman,
British West Indies or call their agent Charles Miller at 800-801-9276 Fax 800-259-0758. Reticulose comes 21 vials to a
case. For HIV , sources familiar with the product suggested that the treatment series be repeated once every 6 months. These
same sources tell me that if the person is also taking AZT, 3TC, D4T, DDC or other similiar drugs that they will be wasting
their money on Reticulose as these treatments are not compatible. AZT used long term is known to suppress the stem cells in
the bone marrow which is immuno-suppressive. Other drugs like Bactrim and Septra, used to prevent PCP, are also known to
suppress both the red and white blood cell counts.

Update: Oct 14, 1995: One PWA who quit AZT 6 months ago and with a CD4 count of 142 used Reticulose for 6 weeks and
increased his CD4 count to 576. His CD4/CD8 improved as well. This PWA did not use any immuno-suppressive drugs with
the Reticulose. The phenomenol results he obtained speaks for itself. More details will be forthcoming in the next newsletter.

Note: Michael S. of San Diego, CA reports he has had very good results with an injectable Colostrum. However, he
provided no specific data. He can be reached at 619-299-5414.

This info can be found at: execpc.com

Mark C.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext